These data support the thesis that LOX-1 is involved in the development of cardiovascular diseases such as atherosclerosis and thrombosis and demonstrate its relationship with low-grade inflammation classified as sterile in the case of diabetes mellitus, hypertension, and metabolic syndrome in patients with dyslipidemia of exogenous or genetic origin. Here, OLR1 is linked to metabolic syndrome.